<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>13(2)</volume><submitter>Pannu AK</submitter><pubmed_abstract>&lt;h4>Introduction&lt;/h4>Despite the widespread use of antivenom for the treatment of snakebite envenoming in the Indian subcontinent, the ideal dose of antivenom has been a point of contention. Low-dose regimens can economize on a scarce resource in low- and middle-income countries. This study assessed the effectiveness of a low-dose (10 vials) antivenom regimen compared to the usual 20 vials in patients with krait bite neuroparalysis requiring mechanical ventilation.&lt;h4>Methods&lt;/h4>This study was a prospective controlled pilot study conducted in a tertiary-care hospital in north India. Participants were eligible if they were ≥12 years old, had krait bite neurotoxicity, showed severe paralysis requiring mechanical ventilation, and had access to antivenom therapy within 24 h of the bite. The p</pubmed_abstract><journal>Toxicology research</journal><pagination>tfae023</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10913380</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Efficacy of a low dose of antivenom for severe neuroparalysis in &amp;lt;i&amp;gt;Bungarus caeruleus&amp;lt;/i&amp;gt; (common krait) envenomation: a pilot study.</pubmed_title><pmcid>PMC10913380</pmcid><pubmed_authors>Dhibar DP</pubmed_authors><pubmed_authors>Pannu AK</pubmed_authors><pubmed_authors>Chand D</pubmed_authors><pubmed_authors>Bhalla A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Efficacy of a low dose of antivenom for severe neuroparalysis in &amp;lt;i&amp;gt;Bungarus caeruleus&amp;lt;/i&amp;gt; (common krait) envenomation: a pilot study.</name><description>&lt;h4>Introduction&lt;/h4>Despite the widespread use of antivenom for the treatment of snakebite envenoming in the Indian subcontinent, the ideal dose of antivenom has been a point of contention. Low-dose regimens can economize on a scarce resource in low- and middle-income countries. This study assessed the effectiveness of a low-dose (10 vials) antivenom regimen compared to the usual 20 vials in patients with krait bite neuroparalysis requiring mechanical ventilation.&lt;h4>Methods&lt;/h4>This study was a prospective controlled pilot study conducted in a tertiary-care hospital in north India. Participants were eligible if they were ≥12 years old, had krait bite neurotoxicity, showed severe paralysis requiring mechanical ventilation, and had access to antivenom therapy within 24 h of the bite. The p</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Apr</publication><modification>2025-04-03T23:32:29.479Z</modification><creation>2025-04-03T23:32:29.479Z</creation></dates><accession>S-EPMC10913380</accession><cross_references><pubmed>38450179</pubmed><doi>10.1093/toxres/tfae023</doi></cross_references></HashMap>